Cellular and molecular mechanisms governing bladder aging
Ended Project Grant Awarded Last action
- Award ID
- R56AG084691
- Recipient
-
Baylor College Of Medicine UEI FXKMA43NTV21
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $396,017
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date
- Place of performance
- Texas, USA
Award details come from USAspending.gov.
Description
- Abstract
- Bladder conditions such as incontinence and urinary tract infections (UTI) are increasingly common with aging and driven by poorly understood changes that occur at the cellular and molecular levels. The objective of this project is to define the molecular pathways that underpin how aging makes the bladder epithelium (urothelium) prone to utis and develop new therapeutics to target those pathways. Data indicate that IFRD1 plays a key role in ribosomal quality control, translation, ER trafficking, and ER stress; and loss of IFRD1 produces aging phenotypes. The central hypothesis is that aging disrupts the cellular function of proteostasis, particularly ribosome dynamics during protein translation, modification, and trafficking between the ER and golgi. Aim 1 will determine the role of ribosomal and translational quality control machinery in the maintenance of bladder homeostasis in young, aged, or IFRD1−/− urothelium of mice. Cycloheximide treatment will be used to inhibit translation in young mice, and translation efficiency will be quantified with a puromycinylation assay to test if treatment is sufficient to induce phenotypes of aging or IFRD1−/− bladders. UTI will be induced using uropathogenic e. Coli., and bladder tissue will be collected to assess molecular-cellular and inflammatory responses using histological analysis, western blots, and QRT-PCR to measure expression of ribosome-associated quality control markers and IFRD1 expression. To determine urothelial-intrinsic role, we will use a newly generated state of the art 3D- murine urothelial organoid system, with the potential to extend investigations to a human urothelial organoid system. Aim 2 will determine whether chronic ER stress is sufficient for promoting aging phenotypes, and if alleviating ER stress will ameliorate the phenotypes. In aged, young, and IFRD1−/− mice bladders and organoids, the expression of ER stress proteins and uroplakins will be compared. Western blots, QRT-PCR, and immunostaining will be used to determine if uroplakin trafficking is altered in aged bladders, as in the IFRD1−/− phenotype. Inflammation, DNA damage, lysosomes, mitochondria, urothelial cell shedding, and expression of ER stress response proteins will be assessed in response to the ER-stressor tunicamycin and ER stress alleviator tudca to determine if this stress drives aging in the urothelium using organoid models. Aim 3 will determine the effects of pharmacological interventions on aging bladder and identify novel proteins governing bladder aging. Understanding the effects and mechanism of action in these drugs will establish a foundation on which translational research can work to develop novel interventions for the treatment of urinary tract conditions that are known to progress with age.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$3,983 | |
| Original award | $400,000 |
Quick answers
Who received award R56AG084691?
R56AG084691 was awarded to Baylor College Of Medicine by National Institute on Aging (National Institutes of Health) on September 15, 2024.
How much is award R56AG084691 worth?
$396,017 has been obligated on R56AG084691.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award